• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与胰岛素抵抗在哮喘发病机制及临床结局中的作用

Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes.

作者信息

Škrgat Sabina, Harlander Matevž, Janić Miodrag

机构信息

Department of Pulmonary Diseases and Allergy, University Medical Centre Ljubljana, SI-1000 Ljubljana, Slovenia.

Medical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

出版信息

Biomedicines. 2024 Jan 12;12(1):173. doi: 10.3390/biomedicines12010173.

DOI:10.3390/biomedicines12010173
PMID:38255279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10813771/
Abstract

Common inflammatory ground links obesity, insulin resistance, and asthma. As recognition of their interplay, one worsening the natural course of the other, is recognised, questions remain about how to adequately address them altogether to improve clinical outcomes. The present manuscript sheds light on the problem, describing possible pathophysiological links, clinical views, and therapeutic challenges, raising questions about what remains to be done, and calling for multidisciplinary treatment of these patients to detect diseases early and adequately address them before they become full-blown and deteriorate their health and quality of life.

摘要

常见的炎症基础将肥胖、胰岛素抵抗和哮喘联系在一起。随着人们认识到它们之间的相互作用,即一种情况会使另一种情况的自然病程恶化,关于如何全面充分地应对这些情况以改善临床结果的问题仍然存在。本手稿阐明了这一问题,描述了可能的病理生理联系、临床观点和治疗挑战,提出了仍有待完成的工作的问题,并呼吁对这些患者进行多学科治疗,以便早期发现疾病并在疾病全面爆发并损害他们的健康和生活质量之前充分应对。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec84/10813771/89b3b2cde94b/biomedicines-12-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec84/10813771/7993245fd8a8/biomedicines-12-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec84/10813771/89b3b2cde94b/biomedicines-12-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec84/10813771/7993245fd8a8/biomedicines-12-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec84/10813771/89b3b2cde94b/biomedicines-12-00173-g002.jpg

相似文献

1
Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes.肥胖与胰岛素抵抗在哮喘发病机制及临床结局中的作用
Biomedicines. 2024 Jan 12;12(1):173. doi: 10.3390/biomedicines12010173.
2
Obesity, Inflammation, and Severe Asthma: an Update.肥胖、炎症与重度哮喘:最新进展
Curr Allergy Asthma Rep. 2021 Dec 18;21(12):46. doi: 10.1007/s11882-021-01024-9.
3
Asthma and Hyperglycemia: Exploring the Interconnected Pathways.哮喘与高血糖:探索相互关联的途径
Diagnostics (Basel). 2024 Aug 26;14(17):1869. doi: 10.3390/diagnostics14171869.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Asthma and insulin resistance in morbidly obese children and adolescents.病态肥胖儿童和青少年中的哮喘与胰岛素抵抗
J Asthma. 2007 Jul-Aug;44(6):469-73. doi: 10.1080/02770900701423597.
6
Insulin resistance modifies the association between obesity and current asthma in adults.胰岛素抵抗改变了成年人肥胖与当前哮喘之间的关联。
Eur Respir J. 2016 Aug;48(2):403-10. doi: 10.1183/13993003.00246-2016. Epub 2016 Apr 21.
7
Recent insight into obesity and asthma.肥胖与哮喘的最新研究进展。
Curr Opin Pulm Med. 2010 Jan;16(1):64-70. doi: 10.1097/MCP.0b013e3283338fa7.
8
Skeletal Muscle Microvascular Dysfunction in Obesity-Related Insulin Resistance: Pathophysiological Mechanisms and Therapeutic Perspectives.肥胖相关胰岛素抵抗中的骨骼肌微血管功能障碍:病理生理机制和治疗展望。
Int J Mol Sci. 2022 Jan 13;23(2):847. doi: 10.3390/ijms23020847.
9
Recent advances in the relationship between obesity, inflammation, and insulin resistance.肥胖、炎症与胰岛素抵抗之间关系的最新进展。
Eur Cytokine Netw. 2006 Mar;17(1):4-12.
10
The "Asthma-Polycystic Ovary Overlap Syndrome" and the Therapeutic Role of Myo-Inositol.“哮喘-多囊卵巢综合征重叠症”与肌醇的治疗作用。
Int J Mol Sci. 2023 Apr 9;24(8):6959. doi: 10.3390/ijms24086959.

引用本文的文献

1
Evaluation of Adipokine Status and Leptin Receptor Gene Polymorphism in Patients with Severe Asthma.重度哮喘患者脂肪因子状态及瘦素受体基因多态性的评估
Diagnostics (Basel). 2025 May 1;15(9):1154. doi: 10.3390/diagnostics15091154.
2
Associated Factors and Pulmonary Function Outcomes of Preserved Ratio Impaired Spirometry: A Scoping Review.肺量计比值保留受损的相关因素及肺功能结果:一项范围综述
Int J Chron Obstruct Pulmon Dis. 2025 Mar 24;20:767-784. doi: 10.2147/COPD.S506115. eCollection 2025.
3
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?

本文引用的文献

1
Identification of extracellular vesicle microRNA signatures specifically linked to inflammatory and metabolic mechanisms in obesity-associated low type-2 asthma.鉴定与肥胖相关的 2 型哮喘中炎症和代谢机制特异性相关的细胞外囊泡 microRNA 特征。
Allergy. 2023 Nov;78(11):2944-2958. doi: 10.1111/all.15824. Epub 2023 Jul 24.
2
The relationship between obstructive sleep apnea and asthma severity and vice versa: a systematic review and meta-analysis.阻塞性睡眠呼吸暂停与哮喘严重程度的关系及反之亦然:系统评价和荟萃分析。
Eur J Med Res. 2023 Mar 30;28(1):139. doi: 10.1186/s40001-023-01097-4.
3
Mechanistic Links Between Obesity and Airway Pathobiology Inform Therapies for Obesity-Related Asthma.
胰高血糖素样肽-1(GLP-1)及胃抑肽/胰高血糖素样肽-1(GIP/GLP-1)受体激动剂在呼吸系统疾病中的潜在应用:我们目前进展如何?
Medicina (Kaunas). 2024 Dec 9;60(12):2030. doi: 10.3390/medicina60122030.
4
Predictive value of triglyceride-glucose index for the occurrence of acute respiratory failure in asthmatic patients of MIMIC-IV database.MIMIC-IV 数据库中哮喘患者三酰甘油-葡萄糖指数对急性呼吸衰竭发生的预测价值。
Sci Rep. 2024 Nov 19;14(1):28631. doi: 10.1038/s41598-024-74294-8.
5
Targeting RAGE-signaling pathways in the repair of rotator-cuff injury.靶向RAGE信号通路修复肩袖损伤
Mol Cell Biochem. 2025 Apr;480(4):2539-2554. doi: 10.1007/s11010-024-05132-8. Epub 2024 Oct 12.
6
Importance of diet in children and adolescents with obesity and asthma.饮食在肥胖和哮喘儿童和青少年中的重要性。
Pediatr Endocrinol Diabetes Metab. 2024;30(2):91-96. doi: 10.5114/pedm.2024.140936.
7
Association between Serum Lipids and Asthma in Adults-A Systematic Review.血清脂质与成年人哮喘的关系:系统评价。
Nutrients. 2024 Jun 28;16(13):2070. doi: 10.3390/nu16132070.
8
Unraveling the Link between Ιnsulin Resistance and Bronchial Asthma.揭示胰岛素抵抗与支气管哮喘之间的联系。
Biomedicines. 2024 Feb 16;12(2):437. doi: 10.3390/biomedicines12020437.
肥胖与气道病理生理学之间的机制联系为肥胖相关哮喘的治疗提供了信息。
Paediatr Drugs. 2023 May;25(3):283-299. doi: 10.1007/s40272-022-00554-7. Epub 2023 Jan 19.
4
Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.阻塞性和限制性通气功能障碍的终身变化模式及其危险因素和结局:一项前瞻性队列研究。
Lancet Respir Med. 2023 Mar;11(3):273-282. doi: 10.1016/S2213-2600(22)00364-2. Epub 2022 Oct 14.
5
Mechanisms of Obesity-related Asthma: Is Insulin Getting on Your Nerves?肥胖相关哮喘的机制:胰岛素在干扰你的神经吗?
Am J Respir Crit Care Med. 2023 Jan 1;207(1):109-110. doi: 10.1164/rccm.202207-1419LE.
6
The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma.胰岛素抵抗对哮喘肺功能丧失和治疗反应的影响。
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1096-1106. doi: 10.1164/rccm.202112-2745OC.
7
Targeting TSLP in Asthma.靶向哮喘中的胸腺基质淋巴细胞生成素(TSLP)
J Asthma Allergy. 2022 Jun 3;15:749-765. doi: 10.2147/JAA.S275039. eCollection 2022.
8
Clinical Characteristics and Management Strategies for Adult Obese Asthma Patients.成年肥胖哮喘患者的临床特征与管理策略
J Asthma Allergy. 2022 May 18;15:673-689. doi: 10.2147/JAA.S285738. eCollection 2022.
9
Asthma Phenotype with Metabolic Dysfunction.代谢功能障碍相关的哮喘表型。
Yonsei Med J. 2022 Jan;63(1):1-7. doi: 10.3349/ymj.2022.63.1.1.
10
TGF-β: The missing link in obesity-associated airway diseases?转化生长因子-β:肥胖相关气道疾病中缺失的环节?
Curr Res Pharmacol Drug Discov. 2021 Feb 5;2:100016. doi: 10.1016/j.crphar.2021.100016. eCollection 2021.